文献速递脑血管病

血管内卒中治疗围手术期平板CT证据的系统综述与荟萃分析

Current Evidence on Periprocedural Flat-Panel CT in Endovascular Stroke Treatment: A Systematic Review and Meta-Analysis
RSS 订阅 · Stroke

非对比FPCT可识别脑实质高密度、蛛网膜下腔高密度和血管内高密度三类影像标志物,并与术后颅内出血、残余远端闭塞及90天功能预后相关。高级血管成像和术后FPCT灌注在血栓显影、残余低灌注检测与最终梗死预测中显示附加价值。

要点

  • 非对比FPCT脑实质高密度常见且提示颅内出血和较差90天功能预后。
  • 血管内高密度「远端闭塞追踪征」对血管内治疗后残余远端闭塞特异性高。
  • 术后FPCT灌注有助于发现残余低灌注并预测最终梗死。

核心结论

  • 围手术期FPCT可在血管内卒中治疗中提供实时诊断信息,帮助识别颅内出血、残余远端闭塞和低灌注。

研究设计与样本

  • 预先注册的系统综述与荟萃分析,按MOOSE指南实施和报告。
  • 检索Medline、Embase和Scopus中2019年1月至2025年9月发表的血管内治疗患者围手术期FPCT研究。

主要发现

  • 非对比FPCT脑实质高密度汇总患病率49%(95% CI,42%–56%)。
  • 脑实质高密度与任何颅内出血相关(OR,10.4;95% CI,4.5–24.1)。
  • 脑实质高密度与脑实质血肿相关(OR,4.3;95% CI,2.2–8.7)。
  • 脑实质高密度与良好预后率降低相关(90天mRS 0–2;OR,0.35;95% CI,0.24–0.50)。
  • 蛛网膜下腔高密度发生率为23%(95% CI,14%–35%),并与远端闭塞和较差良好预后率相关(90天mRS 0–2;OR,0.69;95% CI,0.53–0.91)。

关键数值与推荐

  • 血管内高密度即「远端闭塞追踪征」汇总患病率35%(95% CI,24%–49%)。
  • 「远端闭塞追踪征」对血管内治疗后残余远端闭塞的特异性为93%(95% CI,87%–96%)。

临床怎么用

  • 非对比FPCT可用于血管内治疗后即时筛查颅内出血和残余远端闭塞。
  • 高级血管成像可提高血栓显影和技术成功率。
  • 术后FPCT灌注有助于检测残余低灌注、诊断血流动力学改变并预测最终梗死。

局限性

  • 存在选择偏倚证据,提示上述影像征象可能被轻微过度报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Volume 57, Issue 11, Page 3346-3359, November 1, 2026. BACKGROUND:Periprocedural flat-panel computed tomography (FPCT) may complement real-time decision-making during endovascular treatment for stroke. This study aims to summarize current evidence on diagnostic findings, prognostic associations, and clinical applications of periprocedural FPCT in the angiography suite.METHODS:A systematic review and meta-analysis was preregistered (URL:https://www.crd.york.ac.uk/PROSPERO/; Unique identifier: CRD420251142156), conducted and reported according to MOOSE guidelines (Meta-Analysis of Observational Studies in Epidemiology). Medline, Embase, and Scopus were searched for studies published between January 2019 and September 2025 reporting on periprocedural FPCT in endovascular treatment patients (noncontrast FPCT, 3-dimensional–digital subtraction angiography/contrast-enhanced FPCT, or FPCT perfusion). Random-effects models were used to calculate pooled prevalences and odds ratios for associations with outcomes, primarily functional status assessed via the 90-day modified Rankin Scale score.RESULTS:Forty studies comprising 4139 patients were included. For noncontrast FPCT, 3 distinct imaging biomarkers were identified. Intraparenchymal hyperattenuations were frequent (pooled prevalence 49% [95% CI, 42%–56%]) and associated with any intracranial hemorrhage (odds ratio, 10.4 [95% CI, 4.5–24.1]), parenchymal hematoma (odds ratio, 4.3 [95% CI, 2.2–8.7]) and lower rates of good outcomes (eg, 90-day modified Rankin Scale score 0–2; odds ratio, 0.35 [95% CI, 0.24–0.50]). Subarachnoid hyperattenuations occurred in 23% (95% CI, 14%–35%) of patients and were associated with distal occlusions, markers of procedural aggressiveness, and lower rates of good outcome (eg, 90-day modified Rankin Scale score 0–2; odds ratio, 0.69 [95% CI, 0.53–0.91]). Intravascular hyperattenuations (distal occlusion tracker sign; pooled prevalence 35%, [95% CI, 24%–49%]) showed high specificity (93%, 95% CI, 87%–96%) for residual distal occlusions after endovascular treatment. Advanced vessel imaging improved thrombus conspicuity and technical efficacy, while postoperative flat-panel computed tomography perfusion shows added value for the detection of residual hypoperfusion, diagnosis of hemodynamic alterations, and prediction of final infarct. There was evidence for selection bias, suggesting slight overreporting of the above imaging signs.CONCLUSIONS:Periprocedural FPCT may offer real-tim

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Current Evidence on Periprocedural Flat-Panel CT in Endovascular Stroke Treatment: A Systematic Review and Meta-Analysis

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。